The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Mitochondrial disorders: Prevalence, myths and advances
Abstract
Summary: Disorders of mitochondrial oxidative phosphorylation (OXPHOS) are renowned for their variability in clinical features and genetic causes. This makes it difficult to determine their true prevalence, but recent studies have documented a minimum birth prevalence of 13.1/100 000 or 1/7634 for oxidative phosphorylation disorders with onset at any age. This clearly remains an underestimate but it indicates that oxidative phosphorylation disorders can be regarded as the most common group of inborn errors of metabolism. Pathogenic mutations causing human oxidative phosphorylation disorders have now been identified in more than 30 of the 37 mitochondrial DNA genes and in more than 30 nuclear genes. Most of the nuclear gene defects cause autosomal recessive diseases, but autosomal dominant and X‐linked disorders also occur. It is likely that at least another 30, and perhaps over 100, nuclear‐encoded oxidative phosphorylation disorders await identification. Oxidative phosphorylation genetics are complex and there appear to be a number of common misconceptions about mitochondrial DNA mutations that may impede optimal investigation and management of patients. In our experience, mitochondrial DNA mutations are not a negligible cause of OXPHOS disorders in children but account for 20–25% of cases. Similarly, a family history suggesting maternal inheritance is the exception rather than the norm for children with mitochondrial DNA mutations, many of whom have de novo mutations. Only some mitochondrial DNA mutations disappear from cultured cells, so deficient enzyme activity in fibroblasts does not imply the presence of a nuclear defect. Finally, it is still widely thought that there are very few reproductive options that can be offered to women at risk of transmitting a mitochondrial DNA mutation. While a cautious approach is needed, there is now a consensus that prenatal diagnosis should be offered to some women, particularly those at lower recurrence risk. Preimplantation genetic diagnosis can also be an option.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondrial diseases are caused by genetic mutations in mitochondrial or nuclear DNA that affect the function of the mitochondrial respiratory chain, thereby leading to defective oxidative phosphorylation (Ishikawa and Nakada, 2021; Parikh et al., 2015; Thorburn, 2004).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Thorburn, 2004
Citations
Cites
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
Holt, I. J., Harding, A. E., & MORGAN-HUGHES, J. A. (1988) · Nature · doi:10.1038/331717a0 · Cited by 1,860
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,672
Mitochondrial DNA Deletions in Progressive External Ophthalmoplegia and Kearns-Sayre Syndrome
Moraes, C. T., DiMauro, S., Zeviani, M., Lombès, A., Shanske, S., Miranda, A. F., Nakase, H., Bonilla, E., Werneck, L. C., Servidei, S., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905183202001 · Cited by 1,029
Luft, R., Ikkos, D., Palmieri, G. M. A., Ernster, L., & Afzelius, B. A. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104637 · Cited by 981
Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00926-7 · Cited by 889
Guidelines for the Diagnosis of Rheumatic Fever
Dajani, A. S. (1992) · JAMA · doi:10.1001/jama.1992.03490150121036 · Cited by 830
Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“The frequency of OXPHOS disorders has been said to be 1/5000 to 1/10 000 births (Bourgeron et al 1995; Robinson 1993; Smeitink et al 1998).”
BackgroundWiswell, T. E., Gannon, C. M., Jacob, J., Goldsmith, L. S., Szyld, E. G., Weiss, K., Schutzman, D. L., Cleary, G. M., Filipov, P., Kurlat, I. R., et al. (2000) · PEDIATRICS · doi:10.1542/peds.105.1.1 · Cited by 716
Research works printed but not linked: 1
- Online Mendelian Inheritance in Man 2000. <http://www.ncbi.nlm.nih.gov/omim/>.
Cited by
Sorted by citations
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,650
Self-citationKaufman, B. A., Durisic, N., Mativetsky, J. M., Costantino, S., Hancock, M. A., Grütter, P., & Shoubridge, E. A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0404 · Cited by 431
Evolutionary implications of non-neutral mitochondrial genetic variation
Dowling, D. K., Friberg, U., & LINDELL, J. (2008) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2008.05.011 · Cited by 409
Systematic identification of human mitochondrial disease genes through integrative genomics
Calvo, S. E., Jain, M., Xie, X. S., Sheth, S. A., Chang, B., Goldberger, O., Spinazzola, A., Zeviani, M., Carr, S. A., & Mootha, V. K. (2006) · Nature Genetics · doi:10.1038/ng1776 · Cited by 352
Metadata
- Authors
- Thorburn, D. R.
- Affiliations
- Royal Children's Hospital (AU)
- Corresponding author
- Thorburn, D. R.
- ORCID
- Thorburn, D. R.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 27
- Issue
- 3
- Pages
- 349-362
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2047834942
- Cited by
- 258
- References
- 55
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 11 · 2023: 11 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 8 · 2018: 12 · 2017: 9 · 2016: 19 · 2015: 14 · 2014: 9 · 2013: 20 · 2012: 11
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- mitochondrial disease, oxidative phosphorylation disorders, mitochondrial DNA mutations, birth prevalence, inborn errors of metabolism, maternal inheritance, de novo mutations, prenatal diagnosis, preimplantation genetic diagnosis, fibroblast enzyme activity
- MeSH terms
- Humans, Risk Factors, Prevalence, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
